Literature DB >> 22139560

Protein turnover, ureagenesis and gluconeogenesis.

Yves Schutz1.   

Abstract

The major processes discussed below are protein turnover (degradation and synthesis), degradation into urea, or conversion into glucose (gluconeogenesis, Figure 1). Daily protein turnover is a dynamic process characterized by a double flux of amino acids: the amino acids released by endogenous (body) protein breakdown can be reutilized and reconverted to protein synthesis, with very little loss. Daily rates of protein turnover in humans (300 to 400 g per day) are largely in excess of the level of protein intake (50 to 80 g per day). A fast growing rate, as in premature babies or in children recovering from malnutrition, leads to a high protein turnover rate and a high protein and energy requirement. Protein metabolism (synthesis and breakdown) is an energy-requiring process, dependent upon endogenous ATP supply. The contribution made by whole-body protein turnover to the resting metabolic rate is important: it represents about 20 % in adults and more in growing children. Metabolism of proteins cannot be disconnected from that of energy since energy balance influences net protein utilization, and since protein intake has an important effect on postprandial thermogenesis - more important than that of fats or carbohydrates. The metabolic need for amino acids is essentially to maintain stores of endogenous tissue proteins within an appropriate range, allowing protein homeostasis to be maintained. Thanks to a dynamic, free amino acid pool, this demand for amino acids can be continuously supplied. The size of the free amino acid pool remains limited and is regulated within narrow limits. The supply of amino acids to cover physiological needs can be derived from 3 sources: 1. Exogenous proteins that release amino acids after digestion and absorption 2. Tissue protein breakdown during protein turnover 3. De novo synthesis, including amino acids (as well as ammonia) derived from the process of urea salvage, following hydrolysis and microflora metabolism in the hind gut. When protein intake surpasses the physiological needs of amino acids, the excess amino acids are disposed of by three major processes: 1. Increased oxidation, with terminal end products such as CO₂ and ammonia 2. Enhanced ureagenesis i. e. synthesis of urea linked to protein oxidation eliminates the nitrogen radical 3. Gluconeogenesis, i. e. de novo synthesis of glucose. Most of the amino groups of the excess amino acids are converted into urea through the urea cycle, whereas their carbon skeletons are transformed into other intermediates, mostly glucose. This is one of the mechanisms, essential for life, developed by the body to maintain blood glucose within a narrow range, (i. e. glucose homeostasis). It includes the process of gluconeogenesis, i. e. de novo synthesis of glucose from non-glycogenic precursors; in particular certain specific amino acids (for example, alanine), as well as glycerol (derived from fat breakdown) and lactate (derived from muscles). The gluconeogenetic pathway progressively takes over when the supply of glucose from exogenous or endogenous sources (glycogenolysis) becomes insufficient. This process becomes vital during periods of metabolic stress, such as starvation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22139560     DOI: 10.1024/0300-9831/a000064

Source DB:  PubMed          Journal:  Int J Vitam Nutr Res        ISSN: 0300-9831            Impact factor:   1.784


  27 in total

Review 1.  Frailty and nutrition: searching for evidence.

Authors:  M Bonnefoy; G Berrut; B Lesourd; M Ferry; T Gilbert; O Guérin; O Hanon; C Jeandel; E Paillaud; A Raynaud-Simon; G Ruault; Y Rolland
Journal:  J Nutr Health Aging       Date:  2015-03       Impact factor: 4.075

2.  Human amylin proteotoxicity impairs protein biosynthesis, and alters major cellular signaling pathways in the heart, brain and liver of humanized diabetic rat model in vivo.

Authors:  Amro Ilaiwy; Miao Liu; Traci L Parry; James R Bain; Christopher B Newgard; Jonathan C Schisler; Michael J Muehlbauer; Florin Despa; Monte S Willis
Journal:  Metabolomics       Date:  2016-04-23       Impact factor: 4.290

Review 3.  Urea cycle disorders-update.

Authors:  Shirou Matsumoto; Johannes Häberle; Jun Kido; Hiroshi Mitsubuchi; Fumio Endo; Kimitoshi Nakamura
Journal:  J Hum Genet       Date:  2019-05-20       Impact factor: 3.172

4.  Low hemoglobin levels are associated with upper gastrointestinal bleeding.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Rumiko Hasegawa; Yoshinori Shirai; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  Biomed Rep       Date:  2016-07-27

5.  Patient characteristics with high or low blood urea nitrogen in upper gastrointestinal bleeding.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Rumiko Hasegawa; Yoshinori Shirai; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

6.  Dual proteolytic pathways govern glycolysis and immune competence.

Authors:  Wei Lu; Yu Zhang; David O McDonald; Huie Jing; Bernadette Carroll; Nic Robertson; Qian Zhang; Helen Griffin; Sharon Sanderson; Jeremy H Lakey; Neil V Morgan; Louise N Reynard; Lixin Zheng; Heardley M Murdock; Stuart E Turvey; Scott J Hackett; Tim Prestidge; Julie M Hall; Andrew J Cant; Helen F Matthews; Mauro F Santibanez Koref; Anna Katharina Simon; Viktor I Korolchuk; Michael J Lenardo; Sophie Hambleton; Helen C Su
Journal:  Cell       Date:  2014-12-18       Impact factor: 41.582

7.  Progressive Impairment of Lactate-based Gluconeogenesis in the Huntington's Disease Mouse Model R6/2.

Authors:  Signe Marie Borch Nielsen; Lis Hasholt; Anne Nørremølle; Knud Josefsen
Journal:  PLoS Curr       Date:  2015-04-20

8.  Ammonia-lowering activities and carbamoyl phosphate synthetase 1 (Cps1) induction mechanism of a natural flavonoid.

Authors:  Kazunari Nohara; Youngmin Shin; Noheon Park; Kwon Jeong; Baokun He; Nobuya Koike; Seung-Hee Yoo; Zheng Chen
Journal:  Nutr Metab (Lond)       Date:  2015-06-09       Impact factor: 4.169

9.  Glucagon's Metabolic Action in Health and Disease.

Authors:  Anja Zeigerer; Revathi Sekar; Maximilian Kleinert; Shelly Nason; Kirk M Habegger; Timo D Müller
Journal:  Compr Physiol       Date:  2021-04-01       Impact factor: 9.090

10.  Ketogenic enteral nutrition as a treatment for obesity: short term and long term results from 19,000 patients.

Authors:  Gianfranco Cappello; Antonella Franceschelli; Annalisa Cappello; Paolo De Luca
Journal:  Nutr Metab (Lond)       Date:  2012-10-30       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.